Cargando…
MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate
Studying chemical disturbances during neural differentiation of murine embryonic stem cells (mESCs) has been established as an alternative in vitro testing approach for the identification of developmental neurotoxicants. miRNAs represent a class of small non-coding RNA molecules involved in the regu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045889/ https://www.ncbi.nlm.nih.gov/pubmed/24896083 http://dx.doi.org/10.1371/journal.pone.0098892 |
_version_ | 1782319403035000832 |
---|---|
author | Smirnova, Lena Block, Katharina Sittka, Alexandra Oelgeschläger, Michael Seiler, Andrea E. M. Luch, Andreas |
author_facet | Smirnova, Lena Block, Katharina Sittka, Alexandra Oelgeschläger, Michael Seiler, Andrea E. M. Luch, Andreas |
author_sort | Smirnova, Lena |
collection | PubMed |
description | Studying chemical disturbances during neural differentiation of murine embryonic stem cells (mESCs) has been established as an alternative in vitro testing approach for the identification of developmental neurotoxicants. miRNAs represent a class of small non-coding RNA molecules involved in the regulation of neural development and ESC differentiation and specification. Thus, neural differentiation of mESCs in vitro allows investigating the role of miRNAs in chemical-mediated developmental toxicity. We analyzed changes in miRNome and transcriptome during neural differentiation of mESCs exposed to the developmental neurotoxicant sodium valproate (VPA). A total of 110 miRNAs and 377 mRNAs were identified differently expressed in neurally differentiating mESCs upon VPA treatment. Based on miRNA profiling we observed that VPA shifts the lineage specification from neural to myogenic differentiation (upregulation of muscle-abundant miRNAs, mir-206, mir-133a and mir-10a, and downregulation of neural-specific mir-124a, mir-128 and mir-137). These findings were confirmed on the mRNA level and via immunochemistry. Particularly, the expression of myogenic regulatory factors (MRFs) as well as muscle-specific genes (Actc1, calponin, myosin light chain, asporin, decorin) were found elevated, while genes involved in neurogenesis (e.g. Otx1, 2, and Zic3, 4, 5) were repressed. These results were specific for valproate treatment and―based on the following two observations―most likely due to the inhibition of histone deacetylase (HDAC) activity: (i) we did not observe any induction of muscle-specific miRNAs in neurally differentiating mESCs exposed to the unrelated developmental neurotoxicant sodium arsenite; and (ii) the expression of muscle-abundant mir-206 and mir-10a was similarly increased in cells exposed to the structurally different HDAC inhibitor trichostatin A (TSA). Based on our results we conclude that miRNA expression profiling is a suitable molecular endpoint for developmental neurotoxicity. The observed lineage shift into myogenesis, where miRNAs may play an important role, could be one of the developmental neurotoxic mechanisms of VPA. |
format | Online Article Text |
id | pubmed-4045889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-40458892014-06-09 MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate Smirnova, Lena Block, Katharina Sittka, Alexandra Oelgeschläger, Michael Seiler, Andrea E. M. Luch, Andreas PLoS One Research Article Studying chemical disturbances during neural differentiation of murine embryonic stem cells (mESCs) has been established as an alternative in vitro testing approach for the identification of developmental neurotoxicants. miRNAs represent a class of small non-coding RNA molecules involved in the regulation of neural development and ESC differentiation and specification. Thus, neural differentiation of mESCs in vitro allows investigating the role of miRNAs in chemical-mediated developmental toxicity. We analyzed changes in miRNome and transcriptome during neural differentiation of mESCs exposed to the developmental neurotoxicant sodium valproate (VPA). A total of 110 miRNAs and 377 mRNAs were identified differently expressed in neurally differentiating mESCs upon VPA treatment. Based on miRNA profiling we observed that VPA shifts the lineage specification from neural to myogenic differentiation (upregulation of muscle-abundant miRNAs, mir-206, mir-133a and mir-10a, and downregulation of neural-specific mir-124a, mir-128 and mir-137). These findings were confirmed on the mRNA level and via immunochemistry. Particularly, the expression of myogenic regulatory factors (MRFs) as well as muscle-specific genes (Actc1, calponin, myosin light chain, asporin, decorin) were found elevated, while genes involved in neurogenesis (e.g. Otx1, 2, and Zic3, 4, 5) were repressed. These results were specific for valproate treatment and―based on the following two observations―most likely due to the inhibition of histone deacetylase (HDAC) activity: (i) we did not observe any induction of muscle-specific miRNAs in neurally differentiating mESCs exposed to the unrelated developmental neurotoxicant sodium arsenite; and (ii) the expression of muscle-abundant mir-206 and mir-10a was similarly increased in cells exposed to the structurally different HDAC inhibitor trichostatin A (TSA). Based on our results we conclude that miRNA expression profiling is a suitable molecular endpoint for developmental neurotoxicity. The observed lineage shift into myogenesis, where miRNAs may play an important role, could be one of the developmental neurotoxic mechanisms of VPA. Public Library of Science 2014-06-04 /pmc/articles/PMC4045889/ /pubmed/24896083 http://dx.doi.org/10.1371/journal.pone.0098892 Text en © 2014 Smirnova et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Smirnova, Lena Block, Katharina Sittka, Alexandra Oelgeschläger, Michael Seiler, Andrea E. M. Luch, Andreas MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate |
title | MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate |
title_full | MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate |
title_fullStr | MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate |
title_full_unstemmed | MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate |
title_short | MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate |
title_sort | microrna profiling as tool for in vitro developmental neurotoxicity testing: the case of sodium valproate |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045889/ https://www.ncbi.nlm.nih.gov/pubmed/24896083 http://dx.doi.org/10.1371/journal.pone.0098892 |
work_keys_str_mv | AT smirnovalena micrornaprofilingastoolforinvitrodevelopmentalneurotoxicitytestingthecaseofsodiumvalproate AT blockkatharina micrornaprofilingastoolforinvitrodevelopmentalneurotoxicitytestingthecaseofsodiumvalproate AT sittkaalexandra micrornaprofilingastoolforinvitrodevelopmentalneurotoxicitytestingthecaseofsodiumvalproate AT oelgeschlagermichael micrornaprofilingastoolforinvitrodevelopmentalneurotoxicitytestingthecaseofsodiumvalproate AT seilerandreaem micrornaprofilingastoolforinvitrodevelopmentalneurotoxicitytestingthecaseofsodiumvalproate AT luchandreas micrornaprofilingastoolforinvitrodevelopmentalneurotoxicitytestingthecaseofsodiumvalproate |